Cannabis Bioscience International Holdings, Inc. (CBIH) EBT Margin (2022 - 2026)
Cannabis Bioscience International Holdings (CBIH) posted EBT Margin of 928.47% for Q1 2026, down 334.83% sequentially from 213.53% in Q4 2025, and up 8758.0% YoY from 10.48% in Q1 2025.
Cannabis Bioscience International Holdings, Inc. (CBIH) EBT Margin (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has reported EBT Margin for 5 years, with the latest figure at 928.47% in Q1 2026.
- Quarterly EBT Margin rose 8758.0% year-over-year to 928.47% in Q1 2026, while the trailing twelve-month figure through Feb 2026 was 566.2% (down 45436.0% YoY) and the FY2025 annual result came in at 184.02%, up 7331.0% from the prior year.
- EBT Margin declined to 928.47% in Q1 2026 per CBIH's latest filing, from 213.53% in the prior quarter.
- Over five years, EBT Margin peaked at 56.14% in Q3 2024 and troughed at 1016.05% in Q1 2025.
- A 5-year average of 468.89% and a median of 420.4% in 2022 frame the typical range for EBT Margin.
- The sharpest annual moves came in 2024 and 2025: EBT Margin surged 52212 bps in 2024, then slumped 81595 bps in 2025.
- Over 5 years, EBT Margin stood at 266.27% in 2022, then climbed by 27 bps to 195.19% in 2023, then soared by 53 bps to 92.03% in 2024, then sank by 132 bps to 213.53% in 2025, then sank by 335 bps to 928.47% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 928.47%, 213.53%, and 872.09% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -928.47% |
| Nov 30, 2025 | -213.53% |
| Aug 31, 2025 | -872.09% |
| May 31, 2025 | -775.72% |
| Feb 28, 2025 | -1,016.05% |
| Nov 30, 2024 | -92.03% |
| Aug 31, 2024 | -56.14% |
| May 31, 2024 | -84.63% |
| Feb 29, 2024 | -574.53% |
| Nov 30, 2023 | -195.19% |
| Aug 31, 2023 | -249.64% |
| May 31, 2023 | -606.75% |
| Feb 28, 2023 | -633.45% |
| Nov 30, 2022 | -266.27% |